chr12-57015455-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_013251.4(TAC3):​c.114+229C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0906 in 152,112 control chromosomes in the GnomAD database, including 664 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.091 ( 664 hom., cov: 31)

Consequence

TAC3
NM_013251.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.244

Publications

2 publications found
Variant links:
Genes affected
TAC3 (HGNC:11521): (tachykinin precursor 3) This gene encodes a member of the tachykinin family of secreted neuropeptides. The encoded preproprotein is proteolytically processed to generate the mature peptide, which is primarily expressed in the central and peripheral nervous systems and functions as a neurotransmitter. This peptide is the ligand for the neurokinin-3 receptor. This protein is also expressed in the outer syncytiotrophoblast of the placenta and may be associated with pregnancy-induced hypertension and pre-eclampsia. Mutations in this gene are associated with normosmic hypogonadotropic hypogonadism. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
TAC3 Gene-Disease associations (from GenCC):
  • hypogonadotropic hypogonadism 10 with or without anosmia
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, PanelApp Australia
  • hypogonadotropic hypogonadism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 12-57015455-G-A is Benign according to our data. Variant chr12-57015455-G-A is described in ClinVar as Benign. ClinVar VariationId is 677241.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.172 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013251.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAC3
NM_013251.4
MANE Select
c.114+229C>T
intron
N/ANP_037383.1Q9UHF0-1
TAC3
NM_001178054.2
c.114+229C>T
intron
N/ANP_001171525.1Q9UHF0-3
TAC3
NR_033654.2
n.262+229C>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAC3
ENST00000458521.7
TSL:1 MANE Select
c.114+229C>T
intron
N/AENSP00000404056.2Q9UHF0-1
TAC3
ENST00000441881.5
TSL:1
c.114+229C>T
intron
N/AENSP00000408208.1Q9UHF0-3
TAC3
ENST00000300108.7
TSL:2
n.114+229C>T
intron
N/AENSP00000300108.3Q9UHF0-1

Frequencies

GnomAD3 genomes
AF:
0.0906
AC:
13772
AN:
151994
Hom.:
665
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0816
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.119
Gnomad ASJ
AF:
0.0743
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.107
Gnomad FIN
AF:
0.106
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0811
Gnomad OTH
AF:
0.0821
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0906
AC:
13779
AN:
152112
Hom.:
664
Cov.:
31
AF XY:
0.0934
AC XY:
6947
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.0815
AC:
3382
AN:
41490
American (AMR)
AF:
0.119
AC:
1815
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0743
AC:
258
AN:
3472
East Asian (EAS)
AF:
0.182
AC:
937
AN:
5162
South Asian (SAS)
AF:
0.106
AC:
513
AN:
4818
European-Finnish (FIN)
AF:
0.106
AC:
1121
AN:
10596
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0811
AC:
5510
AN:
67972
Other (OTH)
AF:
0.0836
AC:
177
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
653
1305
1958
2610
3263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0829
Hom.:
422
Bravo
AF:
0.0899
Asia WGS
AF:
0.135
AC:
466
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
3.7
DANN
Benign
0.68
PhyloP100
0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17119330; hg19: chr12-57409239; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.